[144] Silicon Laboratories Inc SEC Filing
The filing is a Form 144 notice from an individual related to Silicon Laboratories Inc. It reports a proposed sale of 2,270 shares of Common stock through Fidelity Brokerage Services on the NASDAQ, with an aggregate market value of $301,206.53 and 32,815,310 shares outstanding for the class. The shares were acquired via an option granted on 01/28/2016 and are indicated as acquired on 08/19/2025; payment is listed as cash. The filer reports no other sales in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information about the issuer.
La comunicazione è un avviso Form 144 presentato da un individuo relativo a Silicon Laboratories Inc. Riporta una proposta di vendita di 2.270 azioni ordinarie tramite Fidelity Brokerage Services sul NASDAQ, con un valore di mercato complessivo di $301.206,53 e 32.815.310 azioni in circolazione per la categoria. Le azioni sono state acquisite tramite un’opzione concessa il 01/28/2016 e risultano acquisite in data 08/19/2025; il pagamento è indicato come contanti. Il dichiarante segnala di non aver effettuato altre vendite negli ultimi tre mesi e include la rappresentazione standard di non essere a conoscenza di informazioni materiali avverse non divulgate sull’emittente.
La presentación es un aviso Form 144 de un individuo relacionado con Silicon Laboratories Inc. Informa de una propuesta de venta de 2.270 acciones ordinarias a través de Fidelity Brokerage Services en el NASDAQ, con un valor de mercado agregado de $301.206,53 y 32.815.310 acciones en circulación para la clase. Las acciones se adquirieron mediante una opción otorgada el 01/28/2016 y se indican como adquiridas el 08/19/2025; el pago figura como efectivo. El declarante informa que no ha realizado otras ventas en los últimos tres meses e incluye la declaración estándar de no tener conocimiento de información adversa material no divulgada sobre el emisor.
해당 제출서류는 Silicon Laboratories Inc. 관련 개인이 제출한 Form 144 통지입니다. 이는 NASDAQ에서 Fidelity Brokerage Services를 통해 보통주 2,270주를 매도할 예정임을 보고하며, 총 시가총액은 $301,206.53이고 해당 등급의 발행주식수는 32,815,310주입니다. 주식은 01/28/2016에 부여된 옵션으로 취득되었고, 08/19/2025에 취득된 것으로 표기되어 있으며; 지급 방식은 현금으로 기재되어 있습니다. 제출인은 지난 3개월간 다른 매도 내역이 없음을 보고하고, 발행인에 대한 미공개 중대한 불리한 정보는 인지하지 못하고 있다는 표준 진술을 포함하고 있습니다.
Le dépôt est un avis Form 144 soumis par un individu lié à Silicon Laboratories Inc. Il signale une proposition de vente de 2 270 actions ordinaires via Fidelity Brokerage Services sur le NASDAQ, pour une valeur de marché globale de 301 206,53 $ et 32 815 310 actions en circulation pour la catégorie. Les actions ont été acquises par le biais d’une option accordée le 01/28/2016 et sont indiquées comme acquises le 08/19/2025 ; le paiement est noté en espèces. Le déclarant indique n’avoir réalisé aucune autre vente au cours des trois derniers mois et inclut la déclaration standard selon laquelle il n’a connaissance d’aucune information défavorable matérielle non divulguée concernant l’émetteur.
Die Einreichung ist eine Form 144-Meldung einer Person im Zusammenhang mit Silicon Laboratories Inc. Sie berichtet über einen geplanten Verkauf von 2.270 Stammaktien über Fidelity Brokerage Services an der NASDAQ, mit einem aggregierten Marktwert von $301.206,53 und 32.815.310 ausstehenden Aktien dieser Klasse. Die Aktien wurden durch eine am 01/28/2016 gewährte Option erworben und als am 08/19/2025 erworben angegeben; die Zahlung ist als Bargeld vermerkt. Der Melder gibt an, in den letzten drei Monaten keine weiteren Verkäufe getätigt zu haben, und enthält die übliche Erklärung, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten bekannt sind.
- Clear disclosure of a proposed sale of 2,270 common shares through Fidelity, providing broker, share count, and market value details
- Acquisition origin stated: shares arose from an option granted on 01/28/2016, clarifying the nature of the holdings
- No sales in past three months reported by the filer, indicating this is not part of a pattern of frequent recent insider dispositions
- None.
Insights
TL;DR: Routine insider notice of a small proposed sale of company stock via broker, no recent sales reported.
This Form 144 discloses a proposed sale of 2,270 common shares for roughly $301k using Fidelity as broker. The shares originate from an option grant dated 2016 and are to be sold in August 2025. There are no reported sales by the filer in the prior three months. For most investors, this filing is a routine compliance disclosure required when officers, directors, or affiliates plan to sell restricted or control securities publicly; it does not by itself indicate material corporate events or changes in fundamentals.
TL;DR: Compliance-focused disclosure consistent with Rule 144; no governance red flags in the notice.
The form documents the mechanics of an intended sale under Rule 144, specifying broker, share count, acquisition method (option grant), and payment. The statement that the signer does not possess undisclosed material adverse information is standard. Absent additional context—such as concurrent insider sales, executive departures, or company disclosures—this filing appears procedural rather than indicative of governance concerns.
La comunicazione è un avviso Form 144 presentato da un individuo relativo a Silicon Laboratories Inc. Riporta una proposta di vendita di 2.270 azioni ordinarie tramite Fidelity Brokerage Services sul NASDAQ, con un valore di mercato complessivo di $301.206,53 e 32.815.310 azioni in circolazione per la categoria. Le azioni sono state acquisite tramite un’opzione concessa il 01/28/2016 e risultano acquisite in data 08/19/2025; il pagamento è indicato come contanti. Il dichiarante segnala di non aver effettuato altre vendite negli ultimi tre mesi e include la rappresentazione standard di non essere a conoscenza di informazioni materiali avverse non divulgate sull’emittente.
La presentación es un aviso Form 144 de un individuo relacionado con Silicon Laboratories Inc. Informa de una propuesta de venta de 2.270 acciones ordinarias a través de Fidelity Brokerage Services en el NASDAQ, con un valor de mercado agregado de $301.206,53 y 32.815.310 acciones en circulación para la clase. Las acciones se adquirieron mediante una opción otorgada el 01/28/2016 y se indican como adquiridas el 08/19/2025; el pago figura como efectivo. El declarante informa que no ha realizado otras ventas en los últimos tres meses e incluye la declaración estándar de no tener conocimiento de información adversa material no divulgada sobre el emisor.
해당 제출서류는 Silicon Laboratories Inc. 관련 개인이 제출한 Form 144 통지입니다. 이는 NASDAQ에서 Fidelity Brokerage Services를 통해 보통주 2,270주를 매도할 예정임을 보고하며, 총 시가총액은 $301,206.53이고 해당 등급의 발행주식수는 32,815,310주입니다. 주식은 01/28/2016에 부여된 옵션으로 취득되었고, 08/19/2025에 취득된 것으로 표기되어 있으며; 지급 방식은 현금으로 기재되어 있습니다. 제출인은 지난 3개월간 다른 매도 내역이 없음을 보고하고, 발행인에 대한 미공개 중대한 불리한 정보는 인지하지 못하고 있다는 표준 진술을 포함하고 있습니다.
Le dépôt est un avis Form 144 soumis par un individu lié à Silicon Laboratories Inc. Il signale une proposition de vente de 2 270 actions ordinaires via Fidelity Brokerage Services sur le NASDAQ, pour une valeur de marché globale de 301 206,53 $ et 32 815 310 actions en circulation pour la catégorie. Les actions ont été acquises par le biais d’une option accordée le 01/28/2016 et sont indiquées comme acquises le 08/19/2025 ; le paiement est noté en espèces. Le déclarant indique n’avoir réalisé aucune autre vente au cours des trois derniers mois et inclut la déclaration standard selon laquelle il n’a connaissance d’aucune information défavorable matérielle non divulguée concernant l’émetteur.
Die Einreichung ist eine Form 144-Meldung einer Person im Zusammenhang mit Silicon Laboratories Inc. Sie berichtet über einen geplanten Verkauf von 2.270 Stammaktien über Fidelity Brokerage Services an der NASDAQ, mit einem aggregierten Marktwert von $301.206,53 und 32.815.310 ausstehenden Aktien dieser Klasse. Die Aktien wurden durch eine am 01/28/2016 gewährte Option erworben und als am 08/19/2025 erworben angegeben; die Zahlung ist als Bargeld vermerkt. Der Melder gibt an, in den letzten drei Monaten keine weiteren Verkäufe getätigt zu haben, und enthält die übliche Erklärung, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten bekannt sind.
FAQ
What does the Form 144 filed for SLAB disclose?
When were the shares acquired according to this Form 144?
Has the filer sold other SLAB securities in the past three months?
Through which broker will the SLAB shares be sold?
What representation does the filer make about material information?
